Uncategorized
MeiraGTx buys back gene therapy from J&J; Storm brings in $56M Series C
MeiraGTx buys back gene therapy from J&J; Storm brings in $56M Series C
💰 MeiraGTx buys back eye gene therapy from J&J for just $25M: The gene therapy, known as bota-vec, failed a Phase 3 study for X-linked retinitis pigmentosa (XLRP) last year. But physicians and patient advocates … Read More